Champions Oncology Inc (CSBR)
Healthcare
Biotechnology
5.40 $
+1.9%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Champions Oncology Inc (CSBR)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 43.7% of the shares are freely tradable; institutional investors hold 47.7%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
47.7%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
26.7%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
43.7%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
1.2%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
14Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Battery Management Corp | 17.44 | 2,421,673 | +0.0 | 03/31/2026 |
| NEA Management Company, LLC | 12.34 | 1,713,720 | +0.0 | 03/31/2026 |
| Vanguard Group Inc | 2.41 | 334,605 | +0.4 | 12/31/2025 |
| Tocqueville Asset Management L.P. | 2.30 | 319,674 | +0.0 | 03/31/2026 |
| Vanguard Capital Management, LLC | 2.16 | 299,520 | +0.0 | 03/31/2026 |
| Morgan Stanley - Brokerage Accounts | 1.74 | 242,300 | +5.5 | 03/31/2026 |
| Renaissance Technologies Corp | 1.05 | 145,539 | -6.0 | 03/31/2026 |
| BlackRock Inc | 0.89 | 123,900 | +0.9 | 03/31/2026 |
| Mink Brook Asset Management LLC | 0.80 | 111,338 | +38.6 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 1.66 | 229,971 | +0.0 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.